CSE: HAVN
OTC: HAVLF
FRA: 5NP
Get Notified
Edit Content
Main Menu
CSE: HAVN
OTC: HAVLF
FRA: 5NP

psychedelic therapy

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder

Leave a Comment / Education, Health & Performance, Psychedelics / By

Novel Nasal-Spray Nano-Formulation Enables Nose-To-Brain Delivery of Biodegradable Nanoparticles that can Encapsulate Psychedelic Substances such as Psilocybin Madrigal Mental Care, a biopharmaceutical company developing a breakthrough delivery system for psychedelic drugs, introduced its novel nanotechnology for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, the premier international Life Science and …

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder Read More »

Collaboration to Provide Peer-to-Peer Support for Veterans Using Psychedelics

Leave a Comment / Education, Health & Performance, Psychedelics / By

Heroic Hearts Project, a nonprofit connecting military Veterans struggling with trauma to psychedelic therapy options, and Fireside Project, a nonprofit helping people minimize risks and fulfill the potential of psychedelic experiences, have announced a partnership that will help ensure Veterans processing past psychedelic experiences may receive free, confidential peer support by phone and text message …

Collaboration to Provide Peer-to-Peer Support for Veterans Using Psychedelics Read More »

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression

Leave a Comment / Education, Health & Performance, Psychedelics / By

Positive Early Signals Seen in Two Investigator-Initiated Studies Presented at the Society of Biological Psychiatry Annual Meeting in New Orleans COMPASS Pathways (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that positive data two investigator-initiated studies demonstrating the potential of COMP360 psilocybin therapy in anorexia …

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression Read More »

LSD: A Future Anti-Anxiety Pill?

Leave a Comment / Education, Health & Performance, Psychedelics / By

New Study by Dr. Gabriella Gobbi Reveals the Neurobiological Mechanisms by which LSD could Relieve Anxiety The craze for psychedelics used for therapeutic purposes is real. However, the scientific evidence supporting their effectiveness and explaining their mode of action in treating mental health disorders is still very thin. A new study led by Dr. Gabriella …

LSD: A Future Anti-Anxiety Pill? Read More »

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients

Leave a Comment / Education, Health & Performance, Psychedelics / By

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients. …

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients Read More »

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression

Leave a Comment / Education, Psychedelics / By

The Medical Research Future Fund Clinical Trials Activity Initiative has awarded $2.7M for Innovative Therapies for Mental Illness to a Monash University-led team, to evaluate the efficacy of psilocybin-assisted psychotherapy in treatment-resistant depression. Major Depressive Disorder (MDD) is, sadly, common, and results in the greatest global burden of disease. Although there are established treatments for …

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression Read More »

University of Wyoming, CaaMTech Team Up to Study Psychedelics as Treatments for Addiction

Leave a Comment / Education, Health & Performance, Psychedelics / By

The University of Wyoming’s School of Pharmacy and CaaMTech, a Washington state-based company that engineers psychedelic drugs, recently formed a collaboration in which UW researchers will evaluate CaaMTech’s proprietary compounds in addiction models as well as aim to demonstrate their anti-addictive properties. Ana Clara Bobadilla, an assistant professor in the UW School of Pharmacy, will lead …

University of Wyoming, CaaMTech Team Up to Study Psychedelics as Treatments for Addiction Read More »

Psychedelics for Pain Management

Leave a Comment / Education, Health & Performance, Psychedelics / By

By Raley Anne James Psychedelic substances have potential for treating physical pain, especially for seniors suffering from chronic pain. However, such potential has long been held back by the strict anti-drug laws that have lumped medically useful substances like psilocybin and cannabis alongside legitimately harmful narcotics such as cocaine and heroin. Fortunately, as discussed in a …

Psychedelics for Pain Management Read More »

What Psychedelic Therapists Should Know As We Head Towards Legalization

Leave a Comment / Education, Plant Medicines, Psychedelics / By

By Bea Chan Legalization is going to happen – it’s just a matter of time. Look at all the US cities already welcoming psychedelics: Santa Cruz, Oakland, Seattle, Denver. There’s no way Canada will be left behind. We already know that people are seeking out the healing benefits of plant and psychedelic medicine. What the …

What Psychedelic Therapists Should Know As We Head Towards Legalization Read More »